Evidence map›Paper›PMID 37688457›Full record

ArticleJournal of neurochemistry2023

Brain-derived neurotrophic factor protects neurons by stimulating mitochondrial function through protein kinase A.

Maryann Swain, Smijin K Soman, Kylea Tapia, Raul Y Dagda, Ruben K Dagda

Open access · greenAbstract read
In one paragraph

Article in Journal of neurochemistry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 27 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Maryann SwainDepartment of Pharmacology, University of Nevada, Reno School of Medicine, Reno, Nevada, USA.ORCID 0000-0002-3094-098X
Smijin K SomanDepartment of Pharmacology, University of Nevada, Reno School of Medicine, Reno, Nevada, USA.ORCID 0000-0002-3891-118X
Kylea TapiaDepartment of Pharmacology, University of Nevada, Reno School of Medicine, Reno, Nevada, USA.
Raul Y DagdaDepartment of Pharmacology, University of Nevada, Reno School of Medicine, Reno, Nevada, USA.
Ruben K DagdaDepartment of Pharmacology, University of Nevada, Reno School of Medicine, Reno, Nevada, USA.
University of Nevada, Reno · US

Funding

Regulation of Dendrite Homeostasis by PINK1 and PKA in Models of Parkinson's DiseaseR01NS105783 · NINDS · UNIVERSITY OF NEVADA RENO · PI DAGDA, RUBEN K · 2018 to 2022
$1.9M
NINDS NIH HHS R01 NS105783
6 · The paper itself

Abstract

Brain-derived neurotrophic factor (BDNF) stimulates dendrite outgrowth and synaptic plasticity by activating downstream protein kinase A (PKA) signaling. Recently, BDNF has been shown to modulate mitochondrial respiration in isolated brain mitochondria, suggesting that BDNF can modulate mitochondrial physiology. However, the molecular mechanisms by which BDNF stimulates mitochondrial function in neurons remain to be elucidated. In this study, we surmised that BDNF binds to the TrkB receptor and translocates to mitochondria to govern mitochondrial physiology in a PKA-dependent manner. Confocal microscopy and biochemical subcellular fractionation assays confirm the localization of the TrkB receptor in mitochondria. The translocation of the TrkB receptor to mitochondria was significantly enhanced upon treating primary cortical neurons with exogenous BDNF, leading to rapid PKA activation. Showing a direct role of BDNF in regulating mitochondrial structure/function, time-lapse confocal microscopy in primary cortical neurons showed that exogenous BDNF enhances mitochondrial fusion, anterograde mitochondrial trafficking, and mitochondrial content within dendrites, which led to increased basal and ATP-linked mitochondrial respiration and glycolysis as assessed by an XF24e metabolic analyzer. BDNF-mediated regulation of mitochondrial structure/function requires PKA activity as treating primary cortical neurons with a pharmacological inhibitor of PKA or transiently expressing constructs that target an inhibitor peptide of PKA (PKI) to the mitochondrion abrogated BDNF-mediated mitochondrial fusion and trafficking. Mechanistically, western/Phos-tag blots show that BDNF stimulates PKA-mediated phosphorylation of Drp1 and Miro-2 to promote mitochondrial fusion and elevate mitochondrial content in dendrites, respectively. Effects of BDNF on mitochondrial function were associated with increased resistance of neurons to oxidative stress and dendrite retraction induced by rotenone. Overall, this study revealed new mechanisms of BDNF-mediated neuroprotection, which entails enhancing mitochondrial health and function of neurons.

Indexed as

Brain-Derived Neurotrophic FactorCyclic AMP-Dependent Protein KinasesCells, CulturedMitochondriaNeuronsReceptor, trkBBrain-Derived Neurotrophic FactorCyclic AMP-Dependent Protein KinasesReceptor, trkBBDNFbioenergeticsmitochondrial dynamicsmitochondrial traffickingPKATrkB

Identifiers

PMID37688457
PMCPMC10543477
OpenAlexW4386564475

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.